Pneumococcal Vaccine, Polyvalent (Pneumovax 23)
Pneumococcal Vaccine, Polyvalent is an FDA-licensed reference biologic from Merck Sharp & Dohme LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1977
Reference approved
Reference product
Pneumovax 23 Pneumococcal Vaccine, Polyvalent
Merck Sharp & Dohme LLC
- Approved
- Nov 21, 1977
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Pneumococcal Vaccine, Polyvalent, in chronological order.
Reference approval
Approval date of the reference Pneumococcal Vaccine, Polyvalent product.
49 yr 3 mo ago
Frequently asked questions
Are there biosimilars approved for Pneumococcal Vaccine, Polyvalent (Pneumovax 23)?
No 351(k) biosimilars or interchangeable biosimilars referencing Pneumococcal Vaccine, Polyvalent are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.